A Natural History of Late Onset Tay-Sachs Disease

NCT02851862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-03-02

No results posted yet for this study

Summary

The purpose of this study is to learn more about the natural history of Late Onset GM2 Gangliosidosis (Tay-Sachs disease and Sandhoff Disease) to inform future clinical trials.

Conditions

  • GM2 Gangliosidosis

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Florian Eichler, MD · Massachusetts General Hospital

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02851862 on ClinicalTrials.gov